Volume 33, Issue 2 (12-2023)
J Mazandaran Univ Med Sci 2023, 33(2): 380-397 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mellati A, Asadi P, Soltanloo N, Fakhar M, Alavizadeh S H, Akhtari J. Application of Liposome Technology in the Treatment of Leishmaniasis: Past, Present and Future. J Mazandaran Univ Med Sci 2023; 33 (2) :380-397
URL: http://jmums.mazums.ac.ir/article-1-16844-en.html
URL: http://jmums.mazums.ac.ir/article-1-16844-en.html
Amir Mellati 
, Peyman Asadi , Nahid Soltanloo , Mahdi Fakhar , Seyedeh Hoda Alavizadeh , Javad Akhtari
, Peyman Asadi , Nahid Soltanloo , Mahdi Fakhar , Seyedeh Hoda Alavizadeh , Javad Akhtari
Abstract: (577 Views)
Leishmaniasis is one of the most common parasitic diseases in tropical and subtropical regions worldwide and poses a threat to public health. According to the World Health Organization (WHO), the number of leishmaniasis cases worldwide is estimated at 12 million, and the number of people at risk is 350 million. However, leishmaniasis therapies have their limitations, and today nanoparticle delivery systems such as liposomes are used. Liposomes are bilayered structures made of phospholipids and cholesterol, which contain hydrophilic and hydrophobic components in their structure and enable the uptake of hydrophobic, hydrophilic, or amphiphilic compounds.
Since the leishmaniasis parasite is predominantly found in macrophages, drug delivery systems improve the therapeutic index of anti-leishmaniasis drugs and reduce the effective dose and toxic off-target effects of non-specific biodistribution.
Targeted liposomal drug delivery systems are achieved by utilizing their different structural features such as particle size and surface charge and attaching other ligands to the surface of liposomes for targeted drug delivery.
Today, sugar-coated liposomes, cationic liposomes, arsenoliposomes and peptide-targeted liposomes are used to deliver traditional anti-leishmaniasis drugs to Leishmania, and due to the importance of nanoliposomes and their many benefits, research continues in this field.
Since the leishmaniasis parasite is predominantly found in macrophages, drug delivery systems improve the therapeutic index of anti-leishmaniasis drugs and reduce the effective dose and toxic off-target effects of non-specific biodistribution.
Targeted liposomal drug delivery systems are achieved by utilizing their different structural features such as particle size and surface charge and attaching other ligands to the surface of liposomes for targeted drug delivery.
Today, sugar-coated liposomes, cationic liposomes, arsenoliposomes and peptide-targeted liposomes are used to deliver traditional anti-leishmaniasis drugs to Leishmania, and due to the importance of nanoliposomes and their many benefits, research continues in this field.
Type of Study: Review |
Subject:
Nano technology
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
